Cargando…
Recent Advances in the Use of Metformin: Can Treating Diabetes Prevent Breast Cancer?
There is substantial epidemiological evidence pointing to an increased incidence of breast cancer and morbidity in obese, prediabetic, and diabetic patients. In vitro studies strongly support metformin, a diabetic medication, in breast cancer therapy. Although metformin has been heralded as an excit...
Autores principales: | Hatoum, Diana, McGowan, Eileen M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4383151/ https://www.ncbi.nlm.nih.gov/pubmed/25866793 http://dx.doi.org/10.1155/2015/548436 |
Ejemplares similares
-
Good Guy or Bad Guy? The Duality of Wild-Type p53 in Hormone-Dependent Breast Cancer Origin, Treatment, and Recurrence
por: McGowan, Eileen M., et al.
Publicado: (2018) -
The Roles of p53 in Mitochondrial Dynamics and Cancer Metabolism: The Pendulum between Survival and Death in Breast Cancer?
por: Moulder, David E., et al.
Publicado: (2018) -
Annexin/S100A Protein Family Regulation through p14ARF-p53 Activation: A Role in Cell Survival and Predicting Treatment Outcomes in Breast Cancer
por: Hatoum, Diana, et al.
Publicado: (2017) -
Mammalian sphingosine kinase (SphK) isoenzymes and isoform expression: challenges for SphK as an oncotarget
por: Hatoum, Diana, et al.
Publicado: (2017) -
Expression Profile of Sphingosine Kinase 1 Isoforms in Human Cancer Tissues and Cells: Importance and Clinical Relevance of the Neglected 1b-Isoform
por: Chen, Hongjie, et al.
Publicado: (2022)